STRS Ohio’s Corbus Pharmaceuticals CRBP Stock Holding History

STRS Ohio’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-430	Closed	-$81K	–	1930
2017 Q2	$81K	Buy	+430	New	+$84.3K	﹤0.01%	1681

Other funds holding CRBP

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

STRS Ohio's CRBP Position: Q3 2017 in Review

STRS Ohio sold out of Corbus Pharmaceuticals (CRBP) in Q3 2017, closing a stake of 430 shares — an estimated $81K sold.

STRS Ohio first reported a position in CRBP in Q2 2017 and held it in 1 quarter. The position peaked at $81K in Q2 2017. 69 funds tracked by Wall St. Rank hold CRBP as of Q3 2017.

STRS Ohio reported no remaining Corbus Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
STRS Ohio sold 430 Corbus Pharmaceuticals shares in Q3 2017, an estimated $81K.
STRS Ohio first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 1 quarter.
STRS Ohio's Corbus Pharmaceuticals position peaked at $81K in Q2 2017.
69 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2017.

Based on STRS Ohio's 13F filing for Q3 2017, filed 23 Oct 2017.